The α5 subunit has been implicated in smoking-related lung cancer, implicated as the primary central nervous system receptor involved in smoking addiction and behavioral patterns, and additionally has been strongly associated with increased lung cancer risk via a nonsynonymous variation in CHRNA5 D398N [27, 30, 31]. Here, CHRNA5 is linked to lung carcinoma.